Internal Medicine, Hematology & Oncology · Cerritos, CA
NPI
1659716959
Since 2013
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
18000 Studebaker Rd Ste 800
Cerritos, CA, 90703
Phone (562) 735-3226
Groups this clinician bills Medicare through
Medicare paid, 2024
$561K
18,142 services
Medicare patients, 2024
122
Average age 74
Drug cost, 2024
$3.8M
1,576 prescriptions
Company payments, 2025
$6,646
From 50 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Babak Baseri was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 430 times for 14 patients. In total Babak Baseri billed 18,142 services in 66 codes, and Medicare paid $561K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 430 | 14 | $0.09 | $36.69 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 364 | 11 | $0.07 | $25.9 |
| 99214 Office E&M - Established | Office | 111 | 50 | $101.40 | $11K |
| 96413 Chemotherapy Administration | Office | 73 | 17 | $110.74 | $8,084 |
| 99213 Office E&M - Established | Office | 66 | 40 | $66.78 | $4,407 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 39 | 11 | $90.46 | $3,528 |
| 96367 Intravenous Infusion, Hydration | Office | 35 | 15 | $23.27 | $814 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 24 | 12 | $0.57 | $13.62 |
| 36415 Venipuncture Blood Collection | Office | 20 | 12 | $8.65 | $173 |
| 99215 Office E&M - Established | Office | 15 | 12 | $151.26 | $2,269 |
| 99442 Telephone Services | Office | 14 | 11 | $54.07 | $757 |
| 99205 Office E&M - New | Office | 14 | 14 | $170.84 | $2,392 |
By year: 2022 $192K for 8,462 services; 2023 $340K for 15,816 services; 2024 $561K for 18,142 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 20 | 12 | $8.65 | $173 |
Medicare prescription drug claims, 2024
In 2024, the drug Babak Baseri prescribed most often to Medicare patients was Letrozole, with 146 prescriptions and refills. In total Babak Baseri wrote 1,576 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 146 | 384 | 57 | $3,796 |
| Prednisone Generic | 74 | 82 | 25 | $387 |
| Hydroxyurea Generic | 69 | 141 | 19 | $1,577 |
| Anastrozole Generic | 64 | 166 | 24 | $1,080 |
| Keytruda Pembrolizumab | 57 | 57 | Under 11 | $627K |
| Bicalutamide Generic | 52 | 91 | 20 | $1,080 |
| Ondansetron Hcl Generic | 51 | 52 | 40 | $1,050 |
| Dexamethasone Generic | 41 | 65 | 31 | $859 |
| Abiraterone Acetate Generic | 38 | 38 | Under 11 | $95K |
| Eliquis Apixaban | 38 | 40 | 13 | $23K |
| Alendronate Sodium Generic | 34 | 92 | 18 | $294 |
| Procrit Epoetin Alfa | 33 | 45 | Under 11 | $38K |
| Trazimera Trastuzumab-Qyyp | 29 | 29 | Under 11 | $88K |
| Tamoxifen Citrate Generic | 28 | 82 | 13 | $1,000 |
| Eligard Leuprolide Acetate | 28 | 82 | 15 | $35K |
Brand drugs: 456 claims; generic drugs: 1,120 claims; opioid claims: 43.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Babak Baseri $6,646 ($6,646 in general payments such as food, travel and fees) from 50 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,334.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 26 | $1,334 |
| AstraZeneca Pharmaceuticals LP AZN | 22 | $555 |
| Janssen Biotech, Inc. JNJ | 18 | $486 |
| Pfizer Inc. PFE | 15 | $331 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 16 | $287 |
| Incyte Corporation INCY | 8 | $252 |
| Karyopharm Therapeutics Inc. KPTI | 7 | $217 |
| Celgene Corporation BMY | 13 | $204 |
| Merck Sharp & Dohme LLC MRK | 8 | $199 |
| Sobi, Inc SOBI.ST | 6 | $195 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.